Cargando…
Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis
OBJECTIVES: Numerous studies have elucidated that circulating tumor cells (CTCs) have significant prognostic value in various solid tumors. However, the prognostic value of CTCs in small cell lung cancer (SCLC) remains controversial. The current study was performed to investigate the prognostic sign...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521771/ https://www.ncbi.nlm.nih.gov/pubmed/34654345 http://dx.doi.org/10.1177/10732748211050581 |
_version_ | 1784584954985840640 |
---|---|
author | Jiang, Ai-Min Zheng, Hao-Ran Liu, Na Zhao, Rui Ma, Yu-Yan Bai, Shu-Heng Tian, Tao Liang, Xuan Ruan, Zhi-Ping Fu, Xiao Yao, Yu |
author_facet | Jiang, Ai-Min Zheng, Hao-Ran Liu, Na Zhao, Rui Ma, Yu-Yan Bai, Shu-Heng Tian, Tao Liang, Xuan Ruan, Zhi-Ping Fu, Xiao Yao, Yu |
author_sort | Jiang, Ai-Min |
collection | PubMed |
description | OBJECTIVES: Numerous studies have elucidated that circulating tumor cells (CTCs) have significant prognostic value in various solid tumors. However, the prognostic value of CTCs in small cell lung cancer (SCLC) remains controversial. The current study was performed to investigate the prognostic significance of different time points of CTCs in SCLC. METHODS: PubMed, EMBASE, Web of Science, and Cochrane Library databases were retrieved for eligible studies. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to investigate the association between CTCs level and overall survival (OS) and progression-free survival (PFS) in SCLC. Furthermore, subgroup analyses, sensitivity analysis, Begg’s and Egger’s tests were also conducted. RESULTS: Sixteen cohort studies with 1103 participants were eligible for this meta-analysis. Our results revealed that higher pretreatment CTCs level was significantly correlated with worse OS in SCLC no matter CellSearch (HR, 2.95; 95%CI, 1.56-5.58; P = .001) or other methods (HR, 2.37; 95%CI, 1.13-4.99; P = .023) was used to detect CTCs. Higher pretreatment CTCs status detected by CellSearch was associated with shorter PFS (HR, 3.75; 95%CI, 2.52-5.57; P < .001), while there was no significant association when other methods were adopted to CTC detection (HR, 2.04; 95%CI, .73-5.68; P = .172). Likewise, we observed that higher post-therapy CTCs level detected by both CellSearch (HR, 2.99; 95%CI, 1.51-5.93; P = .002) and other methods (HR, 4.79; 95%CI, 2.03-11.32; P < .001) was significantly correlated with decreased OS in SCLC. However, higher post-therapy CTCs count detected by CellSearch was not correlated with worse PFS (HR, 1.80; 95%CI, .83-3.90; P = .135). Sensitivity analysis demonstrated that the pooled data were still stable after eliminating studies one by one. However, significant publication bias was observed between pretreatment CTCs level detected by CellSearch and OS of SCLC. CONCLUSION: Dynamic monitoring of CTCs level could be a non-invasive and effective tool to predict the disease progression and prognosis in patients with SCLC. |
format | Online Article Text |
id | pubmed-8521771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-85217712021-10-19 Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis Jiang, Ai-Min Zheng, Hao-Ran Liu, Na Zhao, Rui Ma, Yu-Yan Bai, Shu-Heng Tian, Tao Liang, Xuan Ruan, Zhi-Ping Fu, Xiao Yao, Yu Cancer Control Original Research Article OBJECTIVES: Numerous studies have elucidated that circulating tumor cells (CTCs) have significant prognostic value in various solid tumors. However, the prognostic value of CTCs in small cell lung cancer (SCLC) remains controversial. The current study was performed to investigate the prognostic significance of different time points of CTCs in SCLC. METHODS: PubMed, EMBASE, Web of Science, and Cochrane Library databases were retrieved for eligible studies. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to investigate the association between CTCs level and overall survival (OS) and progression-free survival (PFS) in SCLC. Furthermore, subgroup analyses, sensitivity analysis, Begg’s and Egger’s tests were also conducted. RESULTS: Sixteen cohort studies with 1103 participants were eligible for this meta-analysis. Our results revealed that higher pretreatment CTCs level was significantly correlated with worse OS in SCLC no matter CellSearch (HR, 2.95; 95%CI, 1.56-5.58; P = .001) or other methods (HR, 2.37; 95%CI, 1.13-4.99; P = .023) was used to detect CTCs. Higher pretreatment CTCs status detected by CellSearch was associated with shorter PFS (HR, 3.75; 95%CI, 2.52-5.57; P < .001), while there was no significant association when other methods were adopted to CTC detection (HR, 2.04; 95%CI, .73-5.68; P = .172). Likewise, we observed that higher post-therapy CTCs level detected by both CellSearch (HR, 2.99; 95%CI, 1.51-5.93; P = .002) and other methods (HR, 4.79; 95%CI, 2.03-11.32; P < .001) was significantly correlated with decreased OS in SCLC. However, higher post-therapy CTCs count detected by CellSearch was not correlated with worse PFS (HR, 1.80; 95%CI, .83-3.90; P = .135). Sensitivity analysis demonstrated that the pooled data were still stable after eliminating studies one by one. However, significant publication bias was observed between pretreatment CTCs level detected by CellSearch and OS of SCLC. CONCLUSION: Dynamic monitoring of CTCs level could be a non-invasive and effective tool to predict the disease progression and prognosis in patients with SCLC. SAGE Publications 2021-10-15 /pmc/articles/PMC8521771/ /pubmed/34654345 http://dx.doi.org/10.1177/10732748211050581 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Article Jiang, Ai-Min Zheng, Hao-Ran Liu, Na Zhao, Rui Ma, Yu-Yan Bai, Shu-Heng Tian, Tao Liang, Xuan Ruan, Zhi-Ping Fu, Xiao Yao, Yu Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis |
title | Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis |
title_full | Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis |
title_fullStr | Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis |
title_full_unstemmed | Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis |
title_short | Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis |
title_sort | assessment of the clinical utility of circulating tumor cells at different time points in predicting prognosis of patients with small cell lung cancer: a meta-analysis |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521771/ https://www.ncbi.nlm.nih.gov/pubmed/34654345 http://dx.doi.org/10.1177/10732748211050581 |
work_keys_str_mv | AT jiangaimin assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis AT zhenghaoran assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis AT liuna assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis AT zhaorui assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis AT mayuyan assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis AT baishuheng assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis AT tiantao assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis AT liangxuan assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis AT ruanzhiping assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis AT fuxiao assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis AT yaoyu assessmentoftheclinicalutilityofcirculatingtumorcellsatdifferenttimepointsinpredictingprognosisofpatientswithsmallcelllungcancerametaanalysis |